【Tungs' Hospital】 Former Stage III Prostate Cancer Patient Shares Da Vinci Surgery Experience
【Tungs' Hospital】 Former Stage III Prostate Cancer Patient Shares Da Vinci Surgery Experience
Learn More About【Tungs' Hospital】 figure class="wp-block-uagb-image__figure" style="box-sizing: inherit; margin: 0px; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; position: relative; display: flex; flex-direction: column; max-width: 100%; height: auto;">/figure> Tung’s Taichung MetroHarbor Hospital Continues to Lead in Medical Innovation – Former Patient Shares Inspiring Recovery Journey With 54 years of dedication to patient-centered care, Tungs’ Taichung MetroHarbor Hospital has consistently pursued medical innovation and excellence. In 2012, the hospital became one of Taiwan’s early adopters of the Da Vinci Surgical System. Thirteen years later, it has performed over 5,000 robot-assisted surgeries and now operates two state-of-the-art 4th-generation Da Vinci systems, making it one of the few hospitals in Taiwan with this advanced dual setup. Multi-specialty Collaboration Enhances Precision and Efficiency The Da Vinci system at Tungs’ Hospital is utilized across eight surgical specialties: Thoracic Surgery, Urology, ENT, Obstetrics & Gynecology, General Surgery, Colorectal Surgery, Cardiovascular Surgery, and Pediatric Surgery. By integrating multi-specialty collaboration, the hospital significantly improves surgical precision, reduces recovery time, and enhances overall patient care quality. Some patients even receive coordinated surgeries across departments during a single hospitalization, optimizing both time and medical outcomes. Dr. Yen-Chuan Ou, Director of the Innovation and Research Center, emphasized the continuous refinement of robotic-assisted surgery at Tungs’. From enhanced instrument selection to evidence-based surgical planning, the hospital provides comprehensive care from preoperative evaluation to postoperative recovery. The robot’s high-definition, magnified 3D imaging allows for clearer visualization of blood vessels and nerves, improving both surgical safety and patient recovery. A Life Restored: FormerStage III Prostate CancerPatient Shares Da Vinci Surgery Experience To mark the achievement of over 5,000 Da Vinci surgeries, the hospital hosted a press conference titled “A New Era of Innovation: Breaking 5,000 Da Vinci Cases”, inviting distinguished guests and featuring a moving story from a former patient. Mr. Wu, now 77 years old, underwent Da Vinci-assisted radical prostatectomy at Tungs’ 11 years ago after being diagnosed with stage III prostate cancer. Initially devastated by the diagnosis, he recalled how the medical team, led by Dr. Yen-Chuan Ou, thoroughly explained the treatment plan and reassured him about the robotic surgery. To his surprise, the surgery was nearly painless, and he was able to walk the very next day and was discharged shortly thereafter. With regular follow-up and care, Mr. Wu’s health remains excellent. “I truly got my life back,” he said gratefully. “Thanks to the medical team at Tungs’, I’m living a normal, healthy life again.” figure class="wp-block-uagb-image__figure" style="box-sizing: inherit; margin: 0px; border: 0px; font-style: inherit; font-weight: inherit; outline: 0px; padding: 0px; vertical-align: baseline; position: relative; display: flex; flex-direction: column; max-width: 100%; height: auto;">/figure> A Global Center for Robotic Surgery and Medical Collaboration Over the years, Tungs’ Hospital has become a hub for international medical exchange and surgical observation. Patients now come from Southeast Asia, Europe, and North America, and the hospital welcomes surgeons from around the world to train and observe, particularly in Urology, ENT, and Gynecology, where it is recognized as a world-class center for robotic-assisted surgery. The hospital also organizes the Tungs’ International Congress Series (TICS) annually, providing a high-level platform for global academic exchange in robotic surgery. The event attracts leading medical professionals to share clinical insights, foster innovation, and raise the international standard of care. Superintendent Dr. Tung Min-Che noted that the hospital remains committed to advancing with the latest medical technologies. In 2025, Tungs’ will introduce the new single-port Da Vinci system, expanding its capabilities in minimally invasive and cosmetic procedures. “Our mission is to lead the way in robotic surgery in Asia,” said Dr. Tung. “By investing in advanced equipment and interdisciplinary expertise, we aim to provide patients with safer, more comfortable, and internationally competitive surgical care. -- Official Website:https://tconf.sltung.com.tw/imc/ FB:https://www.facebook.com/ttmhhimsc/ Email: thimsc.tung@gmail.com